Association of IGFBP-6 Expression with Metabolic Syndrome and Adiponectin and IGF-IR Receptor Levels in Colorectal Cancer |
Yunusova, Natalia V
(Tomsk Cancer Research Institute)
Spirina, Liudmila V (Tomsk Cancer Research Institute) Frolova, Alena E (Tomsk Cancer Research Institute) Afanas'ev, Sergey G (Tomsk Cancer Research Institute) Kolegova, Elena S (Tomsk Cancer Research Institute) Kondakova, Irina V (Tomsk Cancer Research Institute) |
1 | Bach LA, Fu P, Yang Z (2013). Insulin-like growth factor-binding protein-6 and cancer. Clin Sci (Lond), 124, 215-29. DOI |
2 | Bach LA (2015). Recent insight into the action of IGFBP-6. J Cell Commun Signal, 9, 189-200. DOI |
3 | Firth SM, Baxter RC (2002). Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev, 23, 824-54. DOI |
4 | Ivanova EV, Kondakova IV, Spirina LV, et al (2014). Chymotrypsin-like activity of proteasomes and total calpain activity in gastric and colorectal cancer. Bulletin Experimental Biol Med, 157, 781-4. DOI |
5 | Kim EJ, Schaffer BS, Kang YH, et al (2002). Decreased production of insulin-like growth factor-binding protein (IGFBP)-6 by transfection of colon cancer cells with an antisense IGFBP-6 cDNA construct leads to stimulation of cell proliferation. J Gastroenterol Hepatol, 17, 563-70. DOI |
6 | Leng SL, Leeding KS, Whitehead RH, et al (2001). Insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-IIinduced but not basal proliferation and adhesion of LIM 1215 colon cancer cells. Mol Cell Endocrinol, 174, 121-7. DOI |
7 | Marinaro JA, Neumann GM, Russo VC, et al (2000). O-glycosylation of insulin-like growth factor (IGF) binding protein-6 maintains high IGF-II binding affinity by decreasing binding to glycosaminoglycans and susceptibility to proteolysis. Eur J Biochem, 267, 5378-86. DOI |
8 | Mauro L, Pellegrino M, De Amicis F, et al (2014). Evidence that estrogen receptor interferes with adiponectin effects on breast cancer cell growth. Cell Cycle, 13, 553-64. DOI |
9 | Mauro L, Naimo GD, Riccio E, et al (2015). Cross-talk between adiponectin and IGF-RI in breast cancer. Frontiers Oncol, 5, 1-8. |
10 | Minniti CP, Luan D, O'Grady C, et al (1995). Insulin-like growth factor II overexpression in myoblasts induces phenotypic changes typical of the malignant phenotype. Cell Growth Differ, 6, 263-9. |
11 | Ogunwobi O, Beales IL (2007). The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3kinase/Akt. Int J Colorectal Dis, 22, 401-9. DOI |
12 | Pennisi PA, Barr V, Nunez NP, et al (2002). Reduced expression of insuline-like growth factor I receptors in MCF breast cancer cells leads to a more metastatic phenotype. Cancer Res, 62, 6529-37. |
13 | Resch A, Langer C (2013). Lymph node staging in colorectal cancer: old controversies and recent advances. World J Gastroenterol, 19, 8515-26. DOI |
14 | Samani AA, Yakar S, LeRoith D, et al (2007). The role of the IGF system in cancer growth and metastasis: overview and recent insight. Endocrine Reviews, 28, 20-47. DOI |
15 | Spirina LV, Bochkareva NV, Kondakova IV, et al (2012). Regulation of insulin-like growth NF- proteasome system in endometrial cancer. Molecular Biol, 46, 407-13. DOI |
16 | Yunusova NV, Kondakova IV, Kolomiets LA, et al (2015). The insulin-like growth factors system in ovarian cancer metastasis: the relation with p45 Ser -catenin. Molekulyrnaya Meditsina, 4, 17-22. [in Russian]. |
17 | Sugiyama M, Takahashi H, Hosono K, et al (2009). Adiponectin inhibits colorectal cancer cell growth through the AMPK/ mTOR pathway. Int J Oncol, 34(2), 339-44. |
18 | Tae CH, Kim SE, Jung SA, et al (2014). Involvement of adiponectin in early stage of colorectal carcinogenesis. BMC Cancer, 14, 811. DOI |
19 | Yunusova NV, Spirina LV, Kondakova IV, et al (2013). The relationship of metalloproteinase PAPP-A expression with the expression of growth and transcriptional factors in endometrial cancer. Biology Bulletin, 40, 253-59. DOI |
20 | Yunusova NV, Kondakova IV, Kolomiets LA, et al (2015). Serum adipokines and their receptors in endometrial and colon cancer patients: relationship with tumor invasion and metastasis. Vopr Onkol, 61, 619-23. |
21 | Zhou JR, Blacurn GL, Walker WA (2007). Symposium introduction: metabolic syndrome and the onset of cancer. Am J Clin Nutr, 86, 817-9. DOI |
22 | Spirina LV, Yunusova NV, Kondakova IV, et al (2012). Association of growth factors, HIF-1 and NF- expression with proteasome in endometrial cancer. Mol Biol Rep, 39, 8655-62. DOI |
23 | Ayyildiz T, Dolar E, Ugras N, et al (2014). Association of adiponectin receptor (Adipo-R1/-R2) expression and colorectal cancer. Asian Pac J Cancer Prev, 15, 9385-90. DOI |
24 | Ahmad W, Shabbiri K, Ijaz B, et al (2011). Serine 204 phosphorylation and O--GlcNAC interplay of IGFBP-6 as therapeutic indicator to regulate IGF-II functions in viral mediated hepatocellular carcinoma. Virol J, 8, 208. DOI |